Dr. Reddy’s Laboratories Q2 Results FY27: Net Profit Falls 31.69% to Rs 913.2 Cr, Revenue Rs 8,697.8 Cr, PAT Rs 913.2 Cr
- October 26, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Dr. Reddy’s Laboratories Q2 Results FY27 were declared on 23 October 2026, with consolidated revenue of Rs 8,697.8 Cr against Rs 8,828.3 Cr a year earlier, a YoY growth of minus 1.48%. Net profit fell 31.69% to Rs 913.2 Cr from Rs 1,336.8 Cr. These quarterly results cover the July to September 2026 period, and Operating Profit came in at Rs 1,730.6 Cr.
Dr. Reddy’s Laboratories Ltd (DRREDDY) Q2 Results FY27 announced on 23 October 2026, covering the company’s financial performance for the July to September quarter. Revenue was Rs 8,697.8 Cr and net profit Rs 913.2 Cr, both on a Consolidated basis, with both lines lower than a year earlier but well above the previous quarter. The Dr. Reddy’s Laboratories Q2 Results FY27 compare each figure with the same quarter last year, as filed on the results date of 23 October 2026. All figures below are consolidated results.
This Dr. Reddy’s Laboratories Q2 Results report is a results analysis of the quarter’s numbers set against the same quarter last year. It covers the financial highlights, the business factors in the data, the outlook for the rest of FY27 and the risks investors can track next, starting with the Financial Highlights below.
Click Here – Get Free Investment Predictions
Dr. Reddy’s Laboratories Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 8697.8 Cr | Rs 8828.3 Cr | -1.48% YoY |
| Operating Profit | Rs 1730.6 Cr | Rs 2009.9 Cr | -13.9% YoY |
| Net Profit (PAT) | Rs 913.2 Cr | Rs 1336.8 Cr | -31.69% YoY |
Source: company filing for Dr. Reddy’s Laboratories Q2 Results FY27, 23 October 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Dr. Reddy’s Laboratories Q2 Results: What Stands Out
- Revenue slipped to Rs 8,697.8 Cr, from Rs 8,828.3 Cr in the same quarter last year, a YoY change of minus 1.48%.
- Net profit fell to Rs 913.2 Cr from Rs 1,336.8 Cr, a decline of 31.69% in the Dr. Reddy’s Laboratories Q2 Results FY27.
- Operating Profit was Rs 1,730.6 Cr, compared with Rs 2,009.9 Cr a year earlier, a YoY change of minus 13.9%.
- Net profit rose 105.5% from the previous quarter, when it stood at Rs 444.30 Cr, so the sequential trend points the other way.
- Net profit margin narrowed to 10.5% from 15.1%, which the performance analysis below sets against the quarter-on-quarter recovery.
Dr. Reddy’s Laboratories Q2 Results FY27: Performance Analysis
The Dr. Reddy’s Laboratories Q2 Results FY27 show consolidated revenue of Rs 8,697.8 Cr and net profit of Rs 913.2 Cr for July to September 2026. Revenue was lower by Rs 130.5 Cr than a year earlier, while net profit was lower by Rs 423.6 Cr. A small dip in sales alongside a much larger fall in profit is the core of this results analysis.
On YoY growth, revenue moved minus 1.48%, Operating Profit minus 13.9% and net profit minus 31.69%. Each line fell further than the one above it, so margins narrowed at every level, with net margin at 10.5% against 15.1%. Readers of the Dr. Reddy’s Laboratories Q2 Results should also note that revenue rose 7.4% and net profit more than doubled from the April to June quarter.
Across the quarterly results of the last five quarters, net profit has ranged from Rs 220.90 Cr to Rs 1,336.80 Cr. This quarter’s Rs 913.2 Cr sits between the two, below the year-ago peak but well above recent lows. Later filings in the Dr. Reddy’s Laboratories Q2 Results FY27 series will show which way the trend settles. The Univest Screener helps compare these numbers with other pharma companies by results date, and that comparison leads into the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Sequential Revenue Recovery – The results analysis points first to revenue, which was up 7.4% quarter on quarter from Rs 8,099.80 Cr. Even though the Dr. Reddy’s Laboratories Q2 Results FY27 show a small YoY dip, sales moved clearly higher from the April to June quarter.
Sequential Profit Recovery – Net profit was up 105.5% quarter on quarter from Rs 444.30 Cr. In these quarterly results, the year-on-year fall sits alongside a sharp rebound from the previous quarter, so the two comparisons tell different stories.
Longer-Term Earnings Record – Earnings on each share roughly doubled between FY22 and FY26. The supplied data confirms this longer record but does not establish the specific cause of this quarter’s lower YoY profit beyond the reported figures.
FY27 Outlook After Dr. Reddy’s Laboratories Q2 Results
The Dr. Reddy’s Laboratories Q2 Results give the second half of FY27 a base of Rs 8,697.8 Cr in quarterly revenue and Rs 913.2 Cr in net profit. No management guidance came with these consolidated results, so this results analysis does not project full-year numbers. The FY27 total will depend on the two remaining quarters and on whether the sequential recovery continues.
In the results analysis that follows the Dr. Reddy’s Laboratories Q2 Results FY27, the useful test is whether net profit keeps rising from this level in the October to December quarter. Investors following the stock on the Univest app can track each quarterly filing as it arrives, and the risks below set out what could change that picture.
Key Risks to Watch After Dr. Reddy’s Laboratories Q2 Results FY27
Lower Revenue
Revenue declined 1.5% year on year to Rs 8,697.80 Cr in the latest quarter. The dip is small, but it means the Dr. Reddy’s Laboratories Q2 Results FY27 did not have top-line growth to lean on against higher costs.
Falling Net Profit and Margin
Net profit fell 31.7% year on year to Rs 913.20 Cr, and net profit margin narrowed to 10.5% from 15.1%. The drop in YoY growth for profit was far steeper than the change in revenue.
Volatile Quarterly Net Profit
Quarterly net profit has been volatile, ranging from Rs 220.90 Cr to Rs 1,336.80 Cr over the last 5 quarters. A swing that wide makes any single quarter a weak guide to the full year.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
The Dr. Reddy’s Laboratories Q2 Results FY27 show consolidated revenue of Rs 8,697.8 Cr, a YoY change of minus 1.48%, and net profit of Rs 913.2 Cr, down 31.69% from a year earlier. These consolidated results are weaker than a year ago but stronger than the previous quarter. Readers of the Dr. Reddy’s Laboratories Q2 Results should weigh both comparisons together. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Dr. Reddy’s Laboratories Q2 Results FY27
What are Dr. Reddy’s Laboratories Q2 Results FY27?
Ans. Dr. Reddy’s Laboratories Q2 Results FY27 show consolidated revenue of Rs 8,697.8 Cr and net profit of Rs 913.2 Cr for July to September 2026, which the opening summary compares with the same quarter last year.
What is the results date for Dr. Reddy’s Laboratories Q2 Results FY27?
Ans. The results date for Dr. Reddy’s Laboratories Q2 Results FY27 was 23 October 2026, when the board approved the quarterly results. Alongside this, the opening section explains which quarter and which basis the filing covers.
What revenue was reported in Dr. Reddy’s Laboratories Q2 Results FY27?
Ans. Dr. Reddy’s Laboratories reported consolidated revenue of Rs 8,697.8 Cr for the July to September quarter, compared with Rs 8,828.3 Cr in the same quarter last year, and the Financial Highlights table lays out that comparison.
What net profit was reported in Dr. Reddy’s Laboratories Q2 Results FY27?
Ans. Dr. Reddy’s Laboratories reported net profit of Rs 913.2 Cr for the quarter, compared with Rs 1,336.8 Cr in the same quarter last year, so the Key Takeaways list opens its profit point with this figure.
How much YoY growth did revenue show in Dr. Reddy’s Laboratories Q2 Results FY27?
Ans. Revenue showed YoY growth of minus 1.48%, slipping from Rs 8,828.3 Cr to Rs 8,697.8 Cr. Alongside this, the Performance Analysis section notes that revenue rose 7.4% from the previous quarter.
Did net profit rise or fall in Dr. Reddy’s Laboratories Q2 Results?
Ans. Dr. Reddy’s Laboratories Q2 Results show net profit fell 31.69% to Rs 913.2 Cr from Rs 1,336.8 Cr a year earlier, though the Performance Analysis section notes it more than doubled from the previous quarter.
What was the Operating Profit in Dr. Reddy’s Laboratories Q2 Results FY27?
Ans. Operating Profit was Rs 1,730.6 Cr in the July to September quarter, compared with Rs 2,009.9 Cr a year earlier, so the Key Takeaways section lists its 13.9% decline beside net profit.
Are Dr. Reddy’s Laboratories Q2 Results consolidated results or standalone results?
Ans. Dr. Reddy’s Laboratories Q2 Results are consolidated results, so the figures include the company and its subsidiaries. Alongside this, the opening paragraphs state the basis before the Financial Highlights table begins.
What business factors shaped Dr. Reddy’s Laboratories Q2 Results FY27?
Ans. Dr. Reddy’s Laboratories Q2 Results FY27 were shaped by a 7.4% rise in revenue and a 105.5% rise in net profit from the previous quarter, as listed in the Key Business Factors section above.
What are the key risks after Dr. Reddy’s Laboratories Q2 Results FY27?
Ans. The key risks are the 1.5% dip in revenue, the 31.7% fall in net profit with a narrower margin, and volatile quarterly profit, as covered in the Key Risks section.
What is the outlook after Dr. Reddy’s Laboratories Q2 Results?
Ans. The filing carried no management guidance, so the rest of FY27 depends on the next two quarters, and the Outlook section lists the figures from this quarter that matter for that.
Where can I find the complete Dr. Reddy’s Laboratories Q2 Results FY27 data?
Ans. The Financial Highlights table in this article carries the complete Dr. Reddy’s Laboratories Q2 Results FY27 figures, and the Univest Screener helps compare these quarterly results with other companies by results date.
